Kathleen Montagu
| Kathleen Montagu | |
|---|---|
| Born |
1847 / 1907 England |
| Died | 28 March 1966 |
| Nationality | British |
| Institutions | Runwell Hospital |
| Known for | Dopamine |
Kathleen Montagu (estimated birth between 1847 and 1907 – March 28, 1966[1]) was the first researcher to identify dopamine in human brains. Working in Hans Weil-Malherbe’s laboratory at the Runwell Hospital outside London[2] the presence of dopamine was identified by paper chromatography in the brain of several species, including a human brain.[3] Her research was published in August 1957,[4] followed and confirmed by Hans Weil-Malherbe in November 1957.[3]
Nobel Prize-rewarded Arvid Carlsson is often claimed to be the first researcher to identify dopamine in human brain, however his research was published in November 1957,[5] along with colleagues Margit Linsqvist and Tor Magnusson.
References
- ↑ Montagu, Kathleen. "Geni". www.geni.com. Geni. Retrieved 31 March 2015.
- ↑ Björklund, Anders. "Fifty Years of Dopamine Research" (PDF). www.cell.com. Elsevier. Retrieved 31 March 2015.
- 1 2 Riederer, Peter. "Parkinson's Disease and Related Disorders". books.google.com. Springer Science & Business Media. Retrieved 31 March 2015.
- ↑ Montagu, Kathleen. "Catechol Compounds in Rat Tissues and in Brains of Different Animals". http://www.nature.com/nature/journal/v180/n4579/abs/180244a0.html. Retrieved 31 March 2015. External link in
|website=(help) - ↑ Carlsson, Arvid. "3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists". www.nature.com. Nature. Retrieved 31 March 2015.
This article is issued from Wikipedia - version of the 12/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.